Indian Drug Exporting Agency Seeks Helps For Domestic Pharmas
This article was originally published in PharmAsia News
Executive Summary
India's Pharmaceuticals Export Promotion Council says it is seeking lower interest rates for the pharmaceutical industry as well as extra promotion of its products abroad. The plans are part of a special package to curtail some of the losses drug makers are suffering during the slow economy and rising cost of raw materials. Pharmexcil is trying to attract more credit for domestic exporters. The industry itself wants loans at lower interest rates and easier terms. Several companies have complained that banks of all types have stopped lending. (Click here for more
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.